Answers are grounded in this paper and cite their sources.
Investigations in paediatric SLE contributed significantly to the discovery of the association of type I IFNs with lupus and underscored the potential application of this knowledge by informing the use of glucocorticoid therapy. Recent, promising research reveals biomarkers that may yield more focused clinical monitoring and assessment of response to treatment. This article reviews unique features of paediatric SLE and details important developments in paediatric lupus research.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: